Gaithersburg, MD, United States of America

Mohammed Dar

This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Medimmune Limited. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammed Dar. Retrieved from https://idiyas.com/inventor/mohammed-dar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mohammed Dar: Innovator in Cancer Treatment Solutions

Introduction

Mohammed Dar is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment through his innovative methods. With a total of 4 patents to his name, Dar is recognized for his dedication to improving patient outcomes.

Latest Patents

Among his latest patents, Mohammed Dar has developed methods for determining treatment for cancer patients. These methods are disclosed in detail, showcasing his commitment to advancing medical science and providing effective solutions for cancer care.

Career Highlights

Dar currently works at MedImmune Limited, where he continues to focus on groundbreaking research and development in the field of oncology. His work has been instrumental in shaping new approaches to cancer treatment.

Collaborations

Throughout his career, Mohammed Dar has collaborated with notable colleagues, including Rajesh Narwal and Paul Robbins. These partnerships have fostered an environment of innovation and shared knowledge, further enhancing the impact of their work.

Conclusion

In summary, Mohammed Dar is a dedicated inventor whose work in cancer treatment is making a significant difference in the medical field. His innovative methods and collaborations highlight his commitment to improving patient care and advancing cancer research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…